Skip to main content
Pharmacology

Immunotherapy

Cancer treatment that activates the immune system to attack cancer cells.

Immunotherapy (checkpoint inhibitors like pembrolizumab, nivolumab; CAR-T therapy) works by overcoming the cancer's mechanisms of immune evasion. Effectiveness depends on biomarkers like PD-L1 and tumor mutational burden.

What this means for you: immunotherapy is typically expensive and not all destinations have it on formulary. Confirm both availability and your tumor's biomarker profile before planning.

General information, not medical advice

What a term means for you depends on your own reports. Ask your treating doctor, or send your reports for a free review.

More Pharmacology terms

Want this explained for your case?

Send your reports once. A doctor reviews them and you get written quotes from up to 3 hospitals, free.

Get free quotes Back to the glossary
How this page is made

Methodology and editorial standards

Glossary entries are written by the Medcasts editorial team in plain language and checked against current clinical and regulatory sources.

  1. Hospital data. Accreditation, licences and facilities are checked against public registries (JCI, NABH, health-ministry licence lists) and hospital documents, and rechecked regularly.
  2. Doctor credentials. Qualifications and specialty come from the doctor's hospital profile and national medical council registers.
  3. Prices. Price ranges come from written hospital quotes and packages, not advertised rates.
  4. Clinical text. Written by our editorial team and checked against current published guidelines before it goes live.
  5. Independence. Hospitals cannot pay to change their position on our pages.